CrossrefInfokarte
Adverse Events Associated with Tirzepatide: Updated Pharmacovigilance Analysis Using FAERS (2022 Q1-2025 Q1) with an Adapted Time-to-Onset Method
Drug, Healthcare and Patient Safety · 2026-01 · Volume 18 · 1-13
DOI: 10.2147/dhps.s556918 ↗Abstract
Kein Abstract verfügbar.
EUVIMED